stockrow
Saturday 7 November 2026
Export DBVT’s income statement to Excel — free account
DBV Technologies S.A.
DBVT Healthcare Biotechnology
DBV Technologies S.A.’s revenue for fiscal 2025 (year ended December 2025) was $5.6 million, up 35.8% from fiscal 2024.
- Revenue
- −42.9%
- EPS
- +40.4%
- Free cash flow
- −64.9%
Quarter to September 2026, against a year earlier
10.57
0.77
+7.86%
Follow DBVT
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
4 | 3 | 3 | 4 | 3 | 2 | 3 | 3 | 2 | 4 |
P/S ratio |
0.00 | 0.00 | 0.00 | 0.00 | 25.14 | 30.79 | 47.93 | 11.45 | 14.44 | 94.95 |
Altman Z-Score |
20.02 | 10.53 | (0.01) | 0.58 | (3.58) | (1.74) | 0.92 | 0.22 | (10.72) | 1.33 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
7.25 | (0.88) | (3.24) | (7.60) | (8.44) | (4.35) | 3.01 | 0.74 | (24.08) | (2.64) |
Beneish M-Score |
— | (3.24) | 6.14 | (2.15) | (3.07) | — | — | — | — | — |
P/Operating CF |
0.00 | 0.00 | 0.00 | 0.00 | (8.45) | (9.35) | (9.72) | (13.16) | (4.89) | (15.21) |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | 1.38 | 1.77 | 1.19 | 1.29 | 2.19 | 3.17 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 1.38 | 1.77 | 1.19 | 1.29 | 2.19 | 3.17 |
EV/Sales |
0.00 | 0.00 | 0.00 | 0.00 | 7.77 | 17.28 | 4.78 | 2.48 | 6.66 | 60.52 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.45 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
0.00 | 0.54 | 0.33 | 0.40 | (0.53) | (0.91) | (0.42) | (0.49) | (0.26) | (2.81) |
EV/FCF |
0.00 | 0.49 | 0.32 | 0.39 | (0.52) | (0.91) | (0.41) | (0.48) | (0.26) | (2.80) |
Quick Ratio |
8.89 | 3.87 | 3.20 | 3.68 | 3.77 | 2.46 | 7.09 | 3.79 | 1.04 | 3.35 |
Current Ratio |
9.38 | 4.37 | 3.34 | 3.79 | 3.93 | 3.64 | 7.56 | 4.26 | 1.43 | 3.67 |
Net Debt/EBITDA |
2.20 | 0.96 | 0.74 | 1.14 | 1.32 | 0.86 | 2.51 | 1.56 | 0.28 | 1.35 |
Debt/Assets |
1.41% | 1.03% | 0.74% | 0.30% | 0.20% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.02 | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.03 | 0.05 | 0.09 | 0.06 | 0.04 | 0.03 | 0.02 | 0.07 | 0.03 | 0.04 |
Operating CF/Net income |
0.52 | 0.77 | 0.82 | 0.86 | 1.04 | 1.11 | 0.58 | 1.10 | 0.92 | 0.82 |
Capex/Depreciation |
(6.08) | (2.58) | (1.68) | (2.16) | (0.26) | (0.04) | (0.06) | 0.05 | 2.53 | (0.17) |
Interest Coverage |
(7,254.23) | (43.60) | (473.55) | (452.44) | (219.40) | (196.87) | (223.56) | — | — | — |
| (40.47%) | (80.34%) | (135.22%) | (102.26%) | (80.04%) | (64.19%) | (65.55%) | (43.47%) | (135.96%) | (149.83%) | |
| (36.25%) | (64.32%) | (97.14%) | (72.49%) | (58.66%) | (46.69%) | (48.96%) | (33.87%) | (91.63%) | (98.17%) | |
ROIC |
0.00% | 0.00% | 0.00% | (14,425.02%) | (1,025.38%) | (280.50%) | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(44.80%) | (106.45%) | (135.97%) | (97.97%) | (88.91%) | (96.71%) | (46.14%) | (54.19%) | (463.87%) | (88.90%) |
Average Days of Receivables |
50.23 | 38.77 | 412.18 | 134.36 | 72.18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
867.76% | 883.64% | 737.23% | 782.59% | 901.09% | 1,232.24% | 1,559.52% | 382.90% | 2,152.30% | 2,070.30% |
Selling, General and Administrative Expense of Revenue |
509.54% | 433.80% | 506.07% | 480.20% | 398.72% | 611.55% | 535.34% | 203.06% | 756.40% | 638.93% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
378.17% | 258.47% | 178.19% | 117.21% | (10.02%) | 54.70% | 103.76% | 38.27% | 111.30% | 95.58% |
Graham Net Nets |
0.00 | 0.00 | 0.00 | 0.00 | 0.50 | 0.38 | 0.74 | 0.64 | 0.10 | 0.28 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(22.55%) | (55.20%) | (102.85%) | (10.56%) | (46.45%) | (56.25%) | (43.33%) | (41.18%) | (187.13%) | (27.57%) |
Free Cash Flow Yield |
0.00% | 0.00% | 0.00% | 0.00% | (59.40%) | (61.78%) | (24.31%) | (44.60%) | (178.22%) | (22.75%) |
Revenue per Share |
2.06 | 2.72 | 2.97 | 1.99 | 1.04 | 0.52 | 0.31 | 0.83 | 0.21 | 0.20 |
Operating CF per Share |
(13.47) | (26.10) | (27.89) | (20.04) | (15.31) | (9.86) | (3.60) | (4.19) | (5.39) | (4.34) |
Capex per Share |
(1.86) | (1.72) | (0.97) | (0.76) | (0.26) | (0.03) | (0.05) | (0.04) | (0.12) | (0.02) |
Free Cash Flow per Share |
(15.33) | (27.82) | (28.86) | (20.80) | (15.56) | (9.88) | (3.64) | (4.22) | (5.51) | (4.36) |
Cash per Share |
58.03 | 31.48 | 25.06 | 26.11 | 18.15 | 7.04 | 13.52 | 7.43 | 1.67 | 6.96 |
Shareholders Equity per Share |
54.95 | 29.66 | 24.76 | 26.10 | 18.99 | 9.04 | 12.56 | 7.37 | 1.41 | 6.05 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
54.95 | 29.66 | 24.76 | 26.10 | 18.99 | 9.04 | 12.56 | 7.37 | 1.41 | 6.05 |
Free Cash Flow |
(74.97) | (137.74) | (166.96) | (153.94) | (168.37) | (108.56) | (56.41) | (80.33) | (106.81) | (121.72) |
Working Capital |
269.10 | 136.69 | 120.37 | 150.55 | 154.66 | 82.99 | 193.55 | 121.58 | 13.25 | 154.92 |
Capital Expenditures |
(9.08) | (8.53) | (5.61) | (5.60) | (2.76) | (0.31) | (0.75) | (0.68) | (2.34) | (0.54) |
Net Current Asset Value |
251.78 | 123.18 | 112.20 | 126.01 | 140.62 | 66.94 | 171.01 | 116.12 | 6.12 | 148.00 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.90 | 0.63 | 0.33 | 0.38 | 0.24 | 0.06 | 0.15 | 0.04 | 0.56 | 0.10 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.11 | 0.16 | 0.14 | 0.10 | 0.42 | 0.46 | 0.87 | (1.11) | (0.08) | 0.31 |
Cash ROIC |
(13.46%) | (45.20%) | (57.62%) | (39.75%) | (41.84%) | (61.48%) | (13.98%) | (28.53%) | (178.49%) | (33.54%) |
Accounts Receivable Turnover |
12.86 | 9.57 | 1.65 | 1.19 | 2.95 | 0.32 | 0.22 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 48.27 | 0.00 | 0.00 | — | — | — |
Average Receivables |
0.78 | 1.41 | 10.41 | 12.40 | 3.82 | 17.64 | 22.10 | — | — | — |
Average Payables |
13.16 | 17.17 | 26.44 | 28.87 | 22.17 | 15.88 | 12.95 | 18.89 | 22.67 | 31.49 |
Average Inventory |
— | — | 1.00 | 2.07 | 2.40 | — | — | — | — | — |
Average Assets |
349.67 | 259.56 | 201.91 | 237.28 | 271.99 | 209.48 | 196.62 | 214.75 | 124.32 | 149.69 |
Average Common Equity |
313.19 | 207.79 | 145.05 | 168.21 | 199.34 | 152.38 | 146.86 | 167.32 | 83.79 | 98.08 |
Columns are period end dates · fundamentals updated 2 Nov 2026